Anti-annexin V antibodies and digital ischemia in patients with scleroderma

Kazumitsu Sugiura, Yoshinao Muro

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective. To elucidate the frequency and clinical significance of anti- annexin V antibodies in patients with scleroderma. Methods. The study population consisted of 66 patients with scleroderma. Their sera were examined for IgG anti-annexin V antibodies by ELISA and immunoblotting. Results. IgG anti-annexin V antibodies were detected by ELISA in 12 patients (18.2%) with scleroderma. Anti-annexin V antibodies were associated with digital ischemia in the patients with scleroderma. Only one patient of the 12 had anticardiolipin antibodies. Although 6 patients with anti-annexin V antibodies were also examined for activated partial thromboplastin time (APTT), none showed prolonged APTT. No IgG anti-annexin V antibodies were detected by immunoblotting. Conclusion. Anti-annexin V antibodies in scleroderma are related to digital ischemia. These antibodies may be associated with the pathogenesis of vascular involvement in scleroderma.

Original languageEnglish
Pages (from-to)2168-2172
Number of pages5
JournalJournal of Rheumatology
Volume26
Issue number10
Publication statusPublished - 27-10-1999
Externally publishedYes

Fingerprint

Annexin A5
Ischemia
Antibodies
Partial Thromboplastin Time
Immunoblotting
Enzyme-Linked Immunosorbent Assay
Anticardiolipin Antibodies
Blood Vessels
Serum
Population

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

@article{17eeaf71a7924bddb4e08bc2d7c91c66,
title = "Anti-annexin V antibodies and digital ischemia in patients with scleroderma",
abstract = "Objective. To elucidate the frequency and clinical significance of anti- annexin V antibodies in patients with scleroderma. Methods. The study population consisted of 66 patients with scleroderma. Their sera were examined for IgG anti-annexin V antibodies by ELISA and immunoblotting. Results. IgG anti-annexin V antibodies were detected by ELISA in 12 patients (18.2{\%}) with scleroderma. Anti-annexin V antibodies were associated with digital ischemia in the patients with scleroderma. Only one patient of the 12 had anticardiolipin antibodies. Although 6 patients with anti-annexin V antibodies were also examined for activated partial thromboplastin time (APTT), none showed prolonged APTT. No IgG anti-annexin V antibodies were detected by immunoblotting. Conclusion. Anti-annexin V antibodies in scleroderma are related to digital ischemia. These antibodies may be associated with the pathogenesis of vascular involvement in scleroderma.",
author = "Kazumitsu Sugiura and Yoshinao Muro",
year = "1999",
month = "10",
day = "27",
language = "English",
volume = "26",
pages = "2168--2172",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",

}

Anti-annexin V antibodies and digital ischemia in patients with scleroderma. / Sugiura, Kazumitsu; Muro, Yoshinao.

In: Journal of Rheumatology, Vol. 26, No. 10, 27.10.1999, p. 2168-2172.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-annexin V antibodies and digital ischemia in patients with scleroderma

AU - Sugiura, Kazumitsu

AU - Muro, Yoshinao

PY - 1999/10/27

Y1 - 1999/10/27

N2 - Objective. To elucidate the frequency and clinical significance of anti- annexin V antibodies in patients with scleroderma. Methods. The study population consisted of 66 patients with scleroderma. Their sera were examined for IgG anti-annexin V antibodies by ELISA and immunoblotting. Results. IgG anti-annexin V antibodies were detected by ELISA in 12 patients (18.2%) with scleroderma. Anti-annexin V antibodies were associated with digital ischemia in the patients with scleroderma. Only one patient of the 12 had anticardiolipin antibodies. Although 6 patients with anti-annexin V antibodies were also examined for activated partial thromboplastin time (APTT), none showed prolonged APTT. No IgG anti-annexin V antibodies were detected by immunoblotting. Conclusion. Anti-annexin V antibodies in scleroderma are related to digital ischemia. These antibodies may be associated with the pathogenesis of vascular involvement in scleroderma.

AB - Objective. To elucidate the frequency and clinical significance of anti- annexin V antibodies in patients with scleroderma. Methods. The study population consisted of 66 patients with scleroderma. Their sera were examined for IgG anti-annexin V antibodies by ELISA and immunoblotting. Results. IgG anti-annexin V antibodies were detected by ELISA in 12 patients (18.2%) with scleroderma. Anti-annexin V antibodies were associated with digital ischemia in the patients with scleroderma. Only one patient of the 12 had anticardiolipin antibodies. Although 6 patients with anti-annexin V antibodies were also examined for activated partial thromboplastin time (APTT), none showed prolonged APTT. No IgG anti-annexin V antibodies were detected by immunoblotting. Conclusion. Anti-annexin V antibodies in scleroderma are related to digital ischemia. These antibodies may be associated with the pathogenesis of vascular involvement in scleroderma.

UR - http://www.scopus.com/inward/record.url?scp=0032829119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032829119&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 2168

EP - 2172

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -